BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30
• 31

• EBD Group Release: BIO-Europe Spring(R) 2009 in Milan Sets New Record for Partnering Productivity

  March 24, 2009

   · 

  1 min read
• Biotech Bay

  Cytokinetics, Inc. Announces Clinical Trials Data Relating to CK-1827452 to be Presented at the 2009 Annual Scientific Sessions of the American College of Cardiology

  March 24, 2009

   · 

  5 min read
• Policy

  Lumavita AG Announces Receipt of Preliminary Approval for Marketing Authorisation of Pentamycin

  March 24, 2009

   · 

  3 min read
• Business

  Ischemix Appoints Robert DuFresne as Chief Executive Officer

  March 24, 2009

   · 

  2 min read
• Drug Development

  Calixa Therapeutics, Inc. Announces Positive Phase 1 Results for CXA-101, a Novel Intravenous Cephalosporin Antibiotic with Excellent Anti-Pseudomonal Activity

  March 24, 2009

   · 

  2 min read
• Business

  Aphios Executes Collaborative R&D Agreement with VivaCell Biotechnology Espana to Develop Combination Therapy For HIV Latency

  March 24, 2009

   · 

  1 min read
• Business

  Flugen, Inc. Secures Exclusive Rights to Novel Vaccine-Delivery Technology

  March 24, 2009

   · 

  1 min read
• Business

  ReGear Life Sciences, Inc. Closes $2.5 Million in Series A Financing Following $1M Investment by Stonewood Capital Management, Inc.

  March 24, 2009

   · 

  2 min read
• Deals

  Flugen, Inc. Secures Exclusive Rights to Novel Vaccine-Delivery Technology

  March 24, 2009

   · 

  3 min read
• Genetown

  Dicerna Pharmaceuticals to Present at the Second Annual Biotechnology Industry Organization (BIO) National Venture Conference

  March 24, 2009

   · 

  1 min read